The global anti-infective agents market is estimated to have reached $109bn in 2018 and is expected to grow at a CAGR of 4.2% during the forecast period. In 2018, the hospital pharmacy segment dominated the distribution channel of the anti-infective agents market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 154-page report you will receive 127 charts– all unavailable elsewhere.
The 154-page report provides clear detailed insight into the anti-infective agents market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Anti-infective Agents Market forecasts from 2019-2029
• Global Anti-infective Agents Market forecasts from 2019-2029 by Type: • Antiviral infections • Antibacterial infections: B-Lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside • Antifungal infections: Azoles, Echinocandins, Polyenes
• Global Anti-infective Agents Market forecasts from 2019-2029 by Indication: • Hepatitis Virus Infection • HIV Infection • Pneumonia • Aspergillosis • Methicillin-resistant Staphylococcus Aureus (MRSA) • Dermatophytosis • Tuberculosis • Respiratory Virus Infection • Sepsis
• Global Anti-infective Agents Market forecasts from 2019-2029 by Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Sales
• Global Anti-infective Agents Market forecasts from 2019-2029 by regional and national market: • North America (US, Canada) • Europe (Germany, UK, France, Rest of Europe) • Asia Pacific (Japan, China, India, Rest of APAC) • RoW (Latin America, Middle East and Africa)
• Profiles of the selected leading companies: • Abbott Laboratories • Bristol-Myers Squibb • GlaxoSmithKline (GSK) • Merck & Co. • Novartis AG • Sanofi SA • Pfizer
• Anti-infective agents R&D Pipeline
• Key Questions Answered by this Report: • How is the Anti-infective Agents market evolving? • What is driving and restraining the Anti-infective Agents market dynamics? • How will each of the submarkets grow over the forecast period and how much revenue will these submarkets account for in 2029? • How will the market shares for each of the Anti-infective Agents submarkets develop from 2019 to 2029? • What will be the main driver for the overall market from 2019-2029? • How will political and regulatory factors influence the regional markets and submarkets? • How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029? • Who are the leading players and what are their prospects over the forecast period? • How will the industry sector evolve during the period between 2019 and 2029?
Visiongain’s study is intended for anyone requiring commercial analyses for the global anti-infective agents Market. You find data, trends and predictions.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview 1.1 Global Anti-infective agents market Overview 1.2 Global Anti-infective agents market Segmentation 1.3 Overview of Findings 1.4 Structure of the Report 1.5 Why You Should Read This Report 1.6 Key Questions Answered by This Analytical Report 1.7 Who is This Report For? 1.8 Methodology 1.9 Frequently Asked Questions (FAQ) 1.10 Associated Visiongain Reports 1.11 About Visiongain
2. Introduction to Anti-infectives 2.1 What Are Anti-infectives? 2.2 Characteristics of Anti-infective agents 2.3 Rare Disease Facts and Statistics 2.4 Common Infectious Diseases Worldwide 2.5 Types of Anti-infectives 2.5.1 Anti-bacterial Drugs 2.5.2 Anti-fungal drugs 2.5.3 Anti-viral drugs 3. Anti-infectives: World Market 2019-2029 3.1 Anti-infective agents market Overview, 2018 3.2 The World Anti-infective Agents market 3.3 World Anti-infective Agents market: Sales Forecast 2019-2029 3.4 Changing Market Shares by Region 2018-2029
4. Anti-infectives: Qualitative Analysis 2019-2029 4.1 Anti-infective Agents Market: Drivers 2019-2029 4.1.1 Increase in Prevalence of Infectious Diseases 4.1.2 High Investment in Anti-infective agents R&D 4.1.3 Growing Support of Government 4.2 Anti-infective agents market Restraints: 2019-2029 4.2.1 Challenges in Research and Development 4.2.2 Stringent Government Regulations
8. Anti-infective Agents market - Pipeline Analysis 2019-2029 8.1 Antibacterials in Development 8.2 Antifungals in Development 8.3 Antivirals in development
9. Leading National Markets 2019-2029 9.1 Geographical Breakdown of the World Anti-infective Agents market 9.2 Global Anti-infective Agents market: Regional Forecast 2019-2029 9.3 How Will Regional Market Shares Change to 2029? 9.4 North America Anti-infective Agents market, 2019-2029 9.4.1 US Anti-infective Agents Market Forecast 2019-2029 9.4.2 Canada Anti-infective Agents Market Forecast 2019-2029 9.5 Europe Anti-infective Agents market, 2019-2029 9.5.1 Europe Anti-infective agents market Forecast 2019-2029 9.5.2 Germany Anti-infective Agents Market Forecast 2019-2029 9.5.3 UK Anti-infective Agents Market Forecast 2019-2029 9.5.4 French Anti-infective Agents Market Forecast 2019-2029 9.5.5 Rest of Europe Anti-infective Agents Market Forecast 2019-2029 9.6 Asia-Pacific Anti-infective Agents Market 2019-2029 9.6.1 Japanese Anti-infective Agents Market Forecast 2019-2029 9.6.2 Chinese Anti-infective Agents Market 2019-2029 9.6.3 Indian Anti-infective Agents Market 2019-2029 9.6.4 Rest of APAC Anti-infective Agents Market Forecast 2019-2029 9.7 RoW Anti-infective Agents Market 2019-2029 9.7.1 Latin American Anti-infective Agents Market Forecast 2019-2029 9.7.2 MEA Anti-infective Agents Market 2019-2029
10. Anti-infective Agents Market: Qualitative Analysis, 2019-2029 10.1 Anti-infective Agents Market: SWOT Analysis, 2019-2029 10.1.1 Strengths 10.1.1.1 Promising Anti-infective Drugs R&D Pipeline 10.1.1.2 Increase in incidence of infectious diseases and healthcare awareness 10.1.2 Weaknesses 10.1.3 High Research and Development Cost 10.1.4 Opportunities 10.1.5 Demand from Emerging Market Continues 10.1.6 Increase in Government Support 10.1.7 Threats 10.1.8 Uncertainty of R&D Results 10.1.9 Barriers to Market Entry 10.2 Anti-infective Agents Market: Porters Five Forces Analysis, 2019-2029 10.2.1 Bargaining Power of Supplier: Moderate 10.2.2 Bargaining Power of Buyer: Medium 10.2.3 Competitive Rivalry: Medium 10.2.4 The Threat of New Entrants: Low 10.2.5 Threat of Substitutes: Medium
List of Figure Figure 1.1 Global Anti-infective agents market Segmentation Overview, 2018 Figure 3.1 Global Anti-infective agents market Forecast Revenue ($bn), AGR (%) 2019-2029 Figure 3.2 Global Anti-infective Agents Market Forecast Share (%) by Region 2018-2029 Figure 4.1 Anti-infective agents market: Drivers 2019-2029 Figure 4.2 Anti-infective agents market: Restraints 2019-2029 Figure 5.1 Global Anti-infective Agents by Indication: Market Share Forecast (%) 2018-2029 Figure 5.2 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2018 Figure 5.3 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2019 Figure 5.4 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2024 Figure 5.5 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2029 Figure 5.6 Global Hepatitis Virus Infection Market Forecast: Revenue ($bn) and AGR (%), 2018-2029 Figure 5.7 Global HIV Infection Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 5.8 Global Pneumonia Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 5.9 Global Aspergillosis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 5.10 Global MRSA Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 5.11 Global Dermatophytosis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 5.12 Global Tuberculosis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 5.13 Global Respiratory Virus Infection Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 5.14 Global Sepsis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.1 Global Anti-infective agents market Forecast by Type Market Share (%) 2019-2029 Figure 6.2 Global Anti-infective Agents Market Forecast by Type: Market Shares (%), 2018 Figure 6.3 Global Anti-infective Agents Market Forecast by Type: Market Shares (%), 2024 Figure 6.4 Global Anti-infective Agents Market Forecast by Type: Market Shares (%), 2029 Figure 6.5 Global Antiviral Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.6 Global Antibacterial infection Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.7 Global B-Lactams Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.8 Global Quinolones Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.9 Global Macrolides Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.10 Global Tetracycline Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.11 Global Aminoglycoside Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.12 Global Antifungal infection Market Forecast: Revenue ($bn) and AGR (%), 2018-2029 Figure 6.13 Global Azoles Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.14 Global Echinocandins Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 6.15 Global Polyenes Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 7.1 Global Anti-infective Agents by Distribution Channel Market Share (%) 2018-2029 Figure 7.2 Global Anti-infective agents by Distribution Channel: Market Shares (%), 2018 Figure 7.3 Global Anti-infective agents by Distribution Channel: Market Shares (%), 2024 Figure 7.4 Global Anti-infective agents by Distribution Channel: Market Shares (%), 2029 Figure 7.5 Global Hospital Pharmacies Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 7.6 Global Retail Pharmacies Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 7.7 Global Online Sales Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.1 Global Anti-infective Agents Market by Region: Revenues (%), 2018 Figure 9.2 Global Anti-infective Agents Market by Region: Revenues (%), 2024 Figure 9.3 Global Anti-infective Agents Market by Region: Revenues (%), 2029 Figure 9.4 North America Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.5 North America Anti-infective Agents Market by Region Forecast: Market Share 2018-2029 Figure 9.6 US Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.7 Canada Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.8 Europe Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.9 Europe Anti-infective Agents Market by Country: Revenue (%), 2018-2029 Figure 9.10 Germany Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.11 UK Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.12 French Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.13 Rest of Europe Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029 Figure 9.14 Rest of Europe Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.15 Asia-Pacific Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.16 Asia-Pacific Anti-infective Agents Market by Country: Revenue (%), 2018-2029 Figure 9.17 Japanese Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.18 Chinese Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.19 Indian Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.20 Rest of APAC Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.21 Latin American Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 9.22 MEA Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029 Figure 10.1 SWOT Analysis of the Global Anti-infective Agents Market, 2019-2029 Figure 11.1 Pfizer: Financial Overview: 2016-2018 Figure 11.2 Bristol-Myers Squibb Company: Financial Overview 2016- 2018 Figure 11.3 Merck & Co., Inc: Financial Overview 2016-2018 Figure 11.4 Novartis: Financial Overview 2016-2018 Figure 11.5 Sanofi S.A.: Financial Overview 2016-2018 Figure 12.1 Global Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%) 2019-2029 Figure 12.2 Global Anti-infective Agents Market Forecast Share (%) by Region 2018, 2024 & 2029
Abbott Laboratories Allergan Amplyx Pharmaceuticals Arno Therapeutics AureoGen Biosciences Bristol-Myers Squibb Celgene Corporation Centers for Disease Control (CDC) Cidara Therapeutics Committee for Medicinal Products for Human Use (CHMP) European Commission (EC) European Medicines Agency (EMA) Food and Drug Administration (FDA) GlaxoSmithKline (GSK) InnoPharma Merck & Co., Inc. Mirati Therapeutics Novartis AG Pfizer Sanofi SA Roche Tokuyama Corporation Vical World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Anti-infective Agents Market Forecast 2019-2029
The oligonucleotide synthesis demand has increased as a result of increased government spending, research and development expenses on pharmaceutical and...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
